CCCC · C4 Therapeutics, Inc. · Proposed Sales
$3.18
+0.29 (+9.90%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$388.76M
Shares
123.03M
Volume · Oct 20
3.69M
Avg daily vol (3M)
2.37M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-08-14 | Mark Mossler | Officer | 4,139 | 2026-08-14 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-14 | JAY GELDMACHER | Former REZI CEO | 82,563 | 2026-08-14 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-13 | Mark Mossler | Officer | 15,000 | 2026-08-13 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-12 | Mark Mossler | Officer | 19,519 | 2026-08-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-28 | Mark Mossler | Former Section 16 Officer | 9,087 | 2026-05-27 | E*Trade |
| 2026-03-09 | JOLIE M SIEGEL | Officer | 101,175 | 2026-03-09 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-11-18 | Salter Malcolm | Director | 13,000 | 2024-11-18 | Morgan Stanley Smith Barney LLC Executive Services |
| 2024-10-18 | Salter Malcolm | Director | 13,000 | 2024-10-18 | Morgan Stanley Smith Barney LLC Executive Services |
| 2024-10-11 | Salter Malcolm | Director | 8,561 | 2024-10-11 | MORGAN STANLEY SMITH BARNEY LLC EXECUTIVE SERVICES |
Showing 1–9 of 9 filings